ABSITE QUESTIONS WITH CORRECT ANSWERS 2025

ABSITE QUESTIONS WITH CORRECT
ANSWERS 2025
2NweeksNafterNaNwhippleNoperation,NyourNpatientNcontinuesNtoNhaveNearlyNsatietyNwithNoralNintake.NYouNd
ecideNtoNstartNmetoglopramideN(Reglan)NandNerythromycin.NWhatNreceptorNdoesNerythromycinNbindNtoNin
creaseNgastrointestinalNmotility?N-NcorrectNanswer-
MotilinN(foundNprimarilyNinNtheNstomach,Nduodenum,NandNcolon)



ProteinsNareNsynthesizedNfrom:



a.NmRNA

b.NtRNA

c.NdsDNA

d.NssDNAN-NcorrectNanswer-mRNA



1NweekNafterNanNAPR,NourNpatientNdevelopsNurosepsisNrequiringNvolumeNresuscitation,Nantibiotics,NandNm
oderateNamountsNofNlevophedNandNvasopressin.NE.NcoliNgrowsNoutNfromNtheNbloodNcultures.NWhatNportio
nNofNtheNlipopolysaccharideNcomplexNaccountsNforNitsNtoxicityN-NcorrectNanswer-
LipidNAN(withNgramNnegativeNsepsis;NstimulatorNofNTNFα)



SteroidNhormones:



a.NBindNaNreceptorNonNtheNplasmaNmembraneNandNactivateNaNplasmaNmembraneNenzyme

b.NBindNaNcytoplasmicNreceptor,NenterNtheNnucleus,NandNaffectNtranscriptionNofNproteins

c.NBindNaNreceptorNinNtheNnucleusNandNaffectNtranscriptionNofNproteins

d.NDoNnotNenterNtheNcellN-NcorrectNanswer-(b)



BindNaNreceptorNinNtheNcellNcytoplasm,NenterNtheNnucleusNasNaNsteroid-
receptorNcomplex,NandNaffectNtranscriptionNofNproteins



4NdaysNafterNanNIvor-LewisNesophagectomy,NyouNdecideNtoNstartNenteralNtubeNfeedingNthroughNaNJ-
tube.NTheNlongNchainNfattyNacidsNcontainedNinNtheNtubeNfeeds:

,a.NEnterNtheNcirculationNviaNtheNportalNsystem

b.NEnterNtheNcirculationNviaNlymphatics

c.NAreNonlyNsynthesizedNinNtheNbody

d.NAreNnotNfoundNinNchylomicronsN-NcorrectNanswer-(b)



Long-
chainNFAsNenterNtheNbodyNthroughNterminalNlactealsN(absorptionNthroughNtheNlymphaticNsystem)NeitherNa
sNfreeNLCFAsNorNasNchylomicrons



Medium-NandNshort-chainNFAsNalongNwithNproteins/CHONenterNthroughNtheNportalNcirculation



CellsNdivideNduringNwhatNphaseNofNtheNcellNcycle?



a.NG1

b.NS

c.NG2

d.NMN-NcorrectNanswer-(d)



CellsNdivideNduringNtheNMNphaseN(mostNradiosensitive)



CellNcycleNlengthNisNdeterminedNbyNwhatNphaseNofNtheNcellNcycle?



a.NG1

b.NS

c.NG2

d.NMN-NcorrectNanswer-(a)



G1N↔NG0NphaseNdeterminesNcellNcycleNlengthN(mostNvariableNcellNperiod)

,MostNRNA/proteinNsynthesis



OfNtheNfollowing,NwhichNisNtheNmostNcriticalNcomponentNinNtheNneovascularizationNofNtumorNmetastases?



a.NHERNreceptor

b.NVEGFNreceptor

c.NNeuNreceptor

d.NFGFNreceptorN-NcorrectNanswer-(d)



VascularNendothelialNgrowthNfactorN(VEGF)Nreceptor



ForNitsNanticoagulationNeffects,NheparinNbinds:



a.NProteinNC

b.NProteinNS

c.NAnti-thrombinNIII

d.NFactorNVIIN-NcorrectNanswer-(c)



ATIIIN(heparin-ATIIINcomplexNbindsNthrombin,NfactorNIX,NfactorNX,NandNfactorNXI)



7NdaysNafterNaNkidneyNtransplant,NyourNpatientNdevelopsNsevereNacuteNrejectionNwithNvasculitisNonNbiopsy.
NYouNdecideNtoNstartNtheNmonoclonalNantibodyNOKT3.NMonoclonalNantibodies:




a.NBindN1NepitopeNatNoneNsite

b.NBindN1NepitopeNatNmultipleNsites

c.NBindNmultipleNepitopesNonNaNsingleNantigen

d.NBindNmultipleNepitopesNonNmultipleNantigensN-NcorrectNanswer-(a)

, TheyNbindNoneNepitopeNatNtheNexactNsameNbindingNsite



YouNstartNcoumadinNonNaNpatientNwithNaNpulmonaryNembolus.NThreeNdaysNlater,NheNstartsNsloughingNoffNs
kinNacrossNhisNarmsNandNlegs.NAllNofNtheNfollowingNareNtrueNofNthisNpatientsNmostNlikelyNconditionNexcept:



a.NThisNlikelyNwouldNhaveNbeenNpreventedNbyNstartingNheparinNbeforeNcoumadin

b.NPatientsNwithNproteinNCNdeficiencyNareNmoreNsusceptibleNtoNthisNproblem

c.NTheNskinNsloughingNisNcausedNbyNskinNnecrosis

d.NThisNisNlikelyNdueNtoNhemophiliaNAN-NcorrectNanswer-(d)



Coumadin-
inducedNskinNnecrosisNoccursNinNpatientsNstartedNonNcoumadinNwithoutNbeingNgivenNheparinNfirst.NItNresul
tsNfromNaNrelativelyNhypercoagulableNstateNthatNcanNoccurNinNsomeNindividualsNbecauseNofNtheNshorterNha
lf-
lifeNofNproteinNCN&NSNcomparedNtoNfactorsNII,NVII,NIX,NandNX.NProteinNCN&NSN↓NafterNcoumadinNbeforeNtheN
otherNfactorsN↓,NresultingNinNaNrelativelyNhypercoagulableNstate.



WhileNperformingNaNLARNforNcolonNcancerNinNaNpatientNonNchronicNdialysis,NyouNnoticeNaNsignificantNamou
ntNofNbloodyNoozingNfromNyourNdissectionNplane.NAllNofNtheNfollowingNareNtrueNofNuremicNinducedNplatelet
NdysfunctionNexcept:




a.NDownNregulatesNGpIb

b.NDownNregulatesNGpIIb/IIIa

c.NStimulatesNvonNWillebrand'sNfactorNrelease

d.NTreatmentNofNchoiceNisNdialysisN-NcorrectNanswer-(c)



UremiaNdownregulatesNGpIb,NGpIIb/IIIa,NandNvWF



DialysisNisNtheNinitialNtreatmentNofNchoiceNforNuremicNcoagulopathy.NOtherNtherapeuticNoptionsNincludeND
DAVPNandNconjugatedNestrogensN(whichNstimulateNtheNreleaseNofNfactorNVIIINandNvWF).



TheNmostNcommonNbloodNtransfusionNreactionNis: